Pediatric IBD: Lymphoma Risk Very Low With Anti-TNF Agents

<![CDATA[]]>(MedPage Today) — AUSTIN — Exposure to tumor necrosis factor (TNF) inhibitors was not linked to lymphoma malignancy among children and adolescents with inflammatory bowel disease (IBD), a researcher said here.
Among 9,281 patients with pediatric…

Source link

Related posts

Clinical characteristics of liver failure with hemophagocytic lymphohistiocytosis


Wet vs. Dry Suction for Fine-Needle Aspiration of Solid Masses


Looking Back at 2019’s Top 10, Peer Tested by You


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World